Sequence and Phenotypic Analysis for Resistance Monitoring in Hepatitis C Virus Drug Development: Recommendations From the HCV DRAG

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2011-03, Vol.140 (3), p.755-760.e12
Hauptverfasser:	Kwong, Ann D, Najera, Isabel, Bechtel, Jill, Bowden, Scott, Fitzgibbon, Joseph, Harrington, Patrick, Kempf, Dale, Kieffer, Tara L, Koletzki, Diana, Kukolj, George, Lim, Sharlene, Pilot–Matias, Tami, Lin, Kai, Mani, Nina, Mo, Hongmei, O'Rear, Jules, Otto, Michael, Parkin, Neil, Pawlotsky, Jean–Michel, Petropoulos, Chris, Picchio, Gaston, Ralston, Robert, Reeves, Jacqueline D, Schooley, Robert T, Seiwert, Scott, Standring, David, Stuyver, Lieven, Sullivan, James, Miller, Veronica
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - therapeutic use Drug Discovery - standards Drug Resistance, Viral - genetics Gastroenterology and Hepatology Genotype Hepacivirus - genetics Hepatitis C - drug therapy Humans Phenotype Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!